Bolt Biotherapeutics (BOLT) Current Assets (2019 - 2025)
Historic Current Assets for Bolt Biotherapeutics (BOLT) over the last 7 years, with Q3 2025 value amounting to $35.6 million.
- Bolt Biotherapeutics' Current Assets fell 3769.4% to $35.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $35.6 million, marking a year-over-year decrease of 3769.4%. This contributed to the annual value of $50.8 million for FY2024, which is 5192.98% down from last year.
- Latest data reveals that Bolt Biotherapeutics reported Current Assets of $35.6 million as of Q3 2025, which was down 3769.4% from $38.3 million recorded in Q2 2025.
- Bolt Biotherapeutics' 5-year Current Assets high stood at $271.2 million for Q1 2021, and its period low was $35.6 million during Q3 2025.
- Its 5-year average for Current Assets is $134.0 million, with a median of $130.7 million in 2023.
- As far as peak fluctuations go, Bolt Biotherapeutics' Current Assets soared by 64586.96% in 2021, and later tumbled by 5527.96% in 2025.
- Bolt Biotherapeutics' Current Assets (Quarter) stood at $189.2 million in 2021, then dropped by 8.68% to $172.7 million in 2022, then plummeted by 38.81% to $105.7 million in 2023, then plummeted by 51.93% to $50.8 million in 2024, then decreased by 29.93% to $35.6 million in 2025.
- Its Current Assets was $35.6 million in Q3 2025, compared to $38.3 million in Q2 2025 and $42.5 million in Q1 2025.